scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1029966578 |
P356 | DOI | 10.1186/1741-7015-8-20 |
P932 | PMC publication ID | 2856521 |
P698 | PubMed publication ID | 20353578 |
P5875 | ResearchGate publication ID | 42767760 |
P50 | author | Douglas G. Altman | Q5300242 |
Patrick Royston | Q61959551 | ||
P2093 | author name string | Susan Mallett | |
Rachel Waters | |||
Susan Dutton | |||
P2860 | cites work | Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 |
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy | Q40367091 | ||
Improvement of breast cancer relapse prediction in high risk intervals using artificial neural networks | Q40377286 | ||
Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma | Q40404767 | ||
International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. | Q40632659 | ||
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors | Q40752297 | ||
Statistical aspects of prognostic factor studies in oncology | Q42388377 | ||
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates | Q43796813 | ||
Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy | Q44234976 | ||
Regression modelling strategies for improved prognostic prediction | Q44912226 | ||
Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection | Q45255770 | ||
Prognosis and prognostic research: Developing a prognostic model | Q45768539 | ||
Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis | Q46329565 | ||
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index | Q46513924 | ||
Prognosis and prognostic research: application and impact of prognostic models in clinical practice | Q46516876 | ||
Time-varying predictors for clinical surveillance of small hepatocellular carcinoma | Q46626073 | ||
A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy | Q46652916 | ||
Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy | Q46731857 | ||
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation. | Q46748907 | ||
A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer | Q46905671 | ||
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia | Q50128112 | ||
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy | Q24596735 | ||
Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey | Q24798774 | ||
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
Assessment and comparison of prognostic classification schemes for survival data. | Q30581228 | ||
Searching for clinical prediction rules in MEDLINE | Q30679969 | ||
Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies | Q30719085 | ||
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines | Q30937722 | ||
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data | Q30979484 | ||
Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy | Q33222555 | ||
Reporting performance of prognostic models in cancer: a review | Q33547696 | ||
What do we mean by validating a prognostic model? | Q33849998 | ||
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients | Q35597216 | ||
A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. | Q35965374 | ||
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy | Q36439622 | ||
The cost of dichotomising continuous variables | Q36468799 | ||
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. | Q36588459 | ||
A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index | Q36614935 | ||
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model | Q36615128 | ||
Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breast | Q36616299 | ||
Reporting of multivariable methods in the medical literature | Q37271414 | ||
Prognostic models: a methodological framework and review of models for breast cancer | Q37416515 | ||
Evaluation of logistic regression reporting in current obstetrics and gynecology literature. | Q51895169 | ||
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. | Q51962427 | ||
Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. | Q52407317 | ||
A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. | Q52409015 | ||
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. | Q52975859 | ||
A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation. | Q53354524 | ||
Reporting of Predictive Logistic Models Should Be Based on Evidence-Based Guidelines | Q57260094 | ||
The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based Registry | Q57304530 | ||
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system | Q57846347 | ||
A population survival model for breast cancer | Q58849647 | ||
A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA | Q59571876 | ||
Bootstrap investigation of the stability of a Cox regression model | Q69532872 | ||
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system | Q80358653 | ||
Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome | Q80392765 | ||
Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy | Q81129450 | ||
Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care | Q81147101 | ||
Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity | Q81170454 | ||
Prognostic index for adult patients with acute myeloid leukemia in first relapse | Q81230380 | ||
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease | Q81308465 | ||
A modified prognostic score for patients with curatively resected gastric cancer | Q81313569 | ||
Dichotomizing continuous predictors in multiple regression: a bad idea | Q81336757 | ||
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma | Q81341152 | ||
Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract | Q81396031 | ||
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy | Q81516651 | ||
A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression | Q81625625 | ||
Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy | Q81639144 | ||
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy | Q81639266 | ||
Prognostic model of event-free survival for patients with androgen-independent prostate carcinoma | Q81673391 | ||
Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy | Q81684119 | ||
Prognostic factors and a scoring system for patients with skeletal metastasis | Q81690849 | ||
A new staging system for colorectal carcinoma with liver metastasis | Q81704652 | ||
Recurrent epithelial ovarian cancer: validation and improvement of an established prognostic index | Q81752031 | ||
Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience | Q81829537 | ||
Prognosis and prognostic research: what, why, and how? | Q83391342 | ||
Prognosis and prognostic research: validating a prognostic model | Q83939735 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neoplasm | Q1216998 |
prognostics | Q3042561 | ||
predictive modelling | Q7239673 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 20 | |
P577 | publication date | 2010-03-30 | |
P1433 | published in | BMC Medicine | Q4835947 |
P1476 | title | Reporting methods in studies developing prognostic models in cancer: a review | |
P478 | volume | 8 |